VF
LGND icon

Virtu Financial’s Ligand Pharmaceuticals LGND Stock Holding History

Virtu Financial’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,049
Closed -$409K – 1947
2026
Q1 		$409K Buy
+2,049
New +$405K 0.02% 657
2025
Q1 		– Sell
-3,155
Closed -$338K – 1725
2024
Q4 		$338K Buy
+3,155
New +$357K 0.02% 646
2023
Q3 		– Sell
-2,945
Closed -$212K – 1620
2023
Q2 		$212K Buy
+2,945
New +$221K 0.02% 782
2020
Q4 		– Sell
-6,135
Closed -$365K – 1624
2020
Q3 		$365K Buy
6,135
+783
+15% +$53.4K 0.06% 369
2020
Q2 		$373K Buy
+5,352
New +$339K 0.04% 471
2019
Q4 		$286K Buy
4,403
+820
+23% +$54.8K 0.03% 708
2019
Q3 		$222K Buy
+3,583
New +$225K 0.02% 910
2019
Q2 		– Sell
-5,497
Closed -$431K – 1674
2019
Q1 		$431K Buy
5,497
+2,988
+119% +$226K 0.02% 633
2018
Q4 		$212K Buy
2,509
+536
+27% +$57.1K 0.01% 926
2018
Q3 		$338K Buy
+1,973
New +$297K 0.02% 790
2018
Q1 		– Sell
-3,562
Closed -$304K – 2299
2017
Q4 		$304K Sell
3,562
-5,921
-62% -$513K 0.02% 1260
2017
Q3 		$805K Buy
+9,483
New +$751K 0.04% 570

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial's LGND Position: Q2 2026 in Review

Virtu Financial sold out of Ligand Pharmaceuticals (LGND) in Q2 2026, closing a stake of 2,049 shares — an estimated $409K sold.

Virtu Financial first reported a position in LGND in Q3 2017 and held it in 12 quarters. The position peaked at $805K in Q3 2017. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Virtu Financial reported no remaining Ligand Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 2,049 Ligand Pharmaceuticals shares in Q2 2026, an estimated $409K.
  • Virtu Financial first reported a position in Ligand Pharmaceuticals in Q3 2017 and held it in 12 quarters.
  • Virtu Financial's Ligand Pharmaceuticals position peaked at $805K in Q3 2017.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.